Clinical Trial Update: A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Shoulder Osteoarthritis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating safety and efficacy of Synvisc for symptomatic shoulder osteoarthritis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Synvisc (Hylan G-F 20)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Osteoarthritis, Musculoskeletal Diseases | Phase 3 | Status: COMPLETED